Tag: cannabis rescheduling

Federal rescheduling may accelerate two distinct THC economies: a pharmaceutical channel built around federally regulated medicines and a state-licensed consumer market built around retail, experience, and brand. The more immediate business question may be what happens when intoxicating-hemp consumers need somewhere else to shop.

WASHINGTON - Americans for Safe Access, Veterans Initiative-22, U.S. Pain Foundation, Realm of Caring, CMM--New Jersey, Montel Williams, Montel Media, ASA San Diego, Michigan for Safe Access, Firefighters...

DEA’s June marijuana-rescheduling hearing will feature seven designated private participants, and every one opposes moving cannabis to Schedule III. The federal government will make the affirmative case, while outside participants representing law enforcement, drug testing, anti-legalization advocacy, state governments, impaired-driving victims, and medical professionals challenge it. Here is who they are and what they’re likely to introduce.

WASHINGTON - Americans for Safe Access (ASA)released a new state guidance memorandum to help governors, state legislators, cannabis regulators, health departments, attorneys general, and state agency...

Before a single witness testifies at the DEA’s June 29 marijuana rescheduling hearing, the most consequential decision may already be made: who gets into the room. Finalizing the approved participant roster on June 22 is the first real indicator of whether the federal government intends to face the multi-billion-dollar commercial reality of the market — or bury it in administrative bureaucracy.

WASHINGTON — Americans for Safe Access (ASA) released a new patient and caregiver guide, “Medical Cannabis Patients: Claim Your Federal Protections & Privileges,” to help medical...

Curaleaf Holdings is making its most tangible move yet toward a major U.S. stock exchange listing with a reverse split of its subordinate shares.

The move to reschedule cannabis is facing its first major judicial test. Following a lawsuit by Smart Approaches to Marijuana (SAM), the industry is left wondering if the shift to Schedule III is in jeopardy. While the April 23 order remains in effect for now, the legal challenge introduces new layers of uncertainty for medical and adult-use operators alike. To maintain stability, companies must look beyond the headlines. We break down the two critical factors that will determine whether federal relief arrives on time or hits a roadblock.

NEW YORK – Former Massachusetts Cannabis Control Commission member Shaleen Title has joined female-led Rudick Law Group as Of Counsel. Title will support clients navigating...

The DEA has launched a portal for state-licensed medical cannabis registration, offering a rare path to federal legitimacy. However, with House Republicans moving to bottle up broader rescheduling and a 60-day window closing fast, operators face both a race for federal protection and an increasingly uncertain climate in D.C.